期刊文献+

Rett综合征患者线粒体DNA突变的初步分析 被引量:3

Mutation analysis of mitochondrial DNA of children with rett syndrome
原文传递
导出
摘要 目的 探讨线粒体DNA在Rett综合征发病中的作用。方法应用Southern杂交、聚合酶链反应(PCR)-单链构象多态性(SSCP)分析及DNA直接测序结合错配PCR的方法,对15例Rett综合征患儿及其中14例的母亲的外周血白细胞线粒体DNA的部分片段进行分析。结果13例患儿及其中11例的母亲的线粒体DNA上,编码16SrRNA基因的2650-3000区域DNA突变,其中7例患儿及其中6例的母亲存在2835位点的点突变(C-T),30例正常对照均未发现有此点突变。结论线粒体DNA在Rett综合征的发病中起一定作用。 Objective To identify whether mitochondrial DNA (mtDNA ) mutation is involved in the patho- genesis of Rett syndrome (RS) , we undertook a mutation analysis of the mtDNA genome. Methods mtDNA from 15 children with RS and 14 their mothers were analysed by usitng Southern hybridization , polymerase chain reaction (PCR ) , single strand conformation polymorphism (SSCP ) and DNA direct sequencing. Total DNA was isolated from white blood cells. Results Southern hybridization with whole mtDNA probe revealed no large deletions in mtDNA. PCR amplification and SSCP analysis showed mutation (s) in the region 26 50-3000 encoding 1 6SrRNA of mtDNA in 1 3 RS patients and 11 their mothers. DNA sequence analysis and mismatch PCR showed a poiant mutation (C-T ) at the posi- tion 2835 in 7 RS patietnts and 6 their mothers. The same mutation was not found in 30 normal con- trols. Conclusion These data indicate that mtDNA may play a role in Rett syndrome.
出处 《中华医学杂志》 CAS CSCD 北大核心 1996年第9期684-687,共4页 National Medical Journal of China
关键词 RETT综合征 DNA线粒体 DNA突变分析 Rett syndrome DNA , mitochondrial DNA mutational analysis
  • 相关文献

参考文献1

  • 1赵东红,中华儿科杂志,1987年,25卷,102页

同被引文献14

  • 1Rett A.On a unusual brain atrophy syndrome inhyperammonemia in child-hood[J].Wien Med Wochenschr,1966,116(37):723-726.
  • 2Amir RE,Van den Veyver IB,Wan M,et al.Rett syndrome is caused by mutations in X-linked MECP2,encoding methyl-CpG-binding protein 2[J].Nat Genet,1999'23(2):185-188.
  • 3Khajuria R,Sapra S,Ghosh M,et al.Rapid detection of deletions in hotspot C-terminal segment region of MECP2 by routine PCR method:report of two classical Rett syndrome patients of Indian origin[J].Genet Test Mol Biomarkers,2009,13(2):277-280.
  • 4Li W,Pozzo-Miller L.BDNF deregulation in Rett sydrone[J].Neurophar-macology,2014,76(Pt C):737-746.
  • 5Moncla A,Kpebe A,Missirian C.Polymorphisms in the C-terminal domain of MECP2 in mentally handicapped boys:implications for genetic coun-selling[J].EurJ Hum Genet,2002,10(1):86-89.
  • 6Laccone F,Zoll B,Huppke P,et al.MECP2 gene nucleotide changes and their pathogenicity in males:proceed with caution[J].J Med Genet,2002,39(8):586-588.
  • 7Sartori S,Di Rosa G,Polli R,et al.A novel CDKL5 mutation in a 47,XXY boy with the early-onset seizure variant of Rett syndrome[J].Am J Med Genet A,2009,149A(2):232-236.
  • 8Kumakura A,Takahashi S,Okajima K,et al.A haploinsufficiency of FOXGl identified in a boy with congenital variant of Rett syndrome[J].Brain Dev,2014,36(8):725-729.
  • 9Naidu S,Hyman S,Harris EL,et al.Rett syndrome studies of natural history and search for a genetic marker[J].Neuropediatrics,1995,26(2):63-66.
  • 10Chapleau CA,Lane J,Pozzo-miller L,et al.Evaluation of current pharmacological treatment options in the management of Rett syndrome:from the present to future therapeutic altematives[J].Curr Clin Pharmacol,2013,8(4):358-369.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部